ArticleHepatology communications2023

High rifaximin out-of-pocket costs are associated with decreased treatment retention among patients with hepatic encephalopathy.

Elizabeth S Aby et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.